Optimize Pharmaceutical Care with AI
Transform oncology pharmacy practice with AI-powered CTCAE grading that improves drug attribution accuracy by 94%, reduces ADR management time by 78%, and enhances patient safety through intelligent toxicity analysis and clinical decision support.
94%
Drug Attribution Accuracy
AI-powered causality assessment
78%
Faster ADR Management
Streamlined adverse reaction workflows
87%
Improved Safety Monitoring
Enhanced patient safety outcomes
92%
Drug Interaction Detection
Proactive interaction identification
Intelligent Drug Attribution & Safety Analysis
AI-powered causality assessment and drug safety monitoring that exceeds manual methods in accuracy and efficiency.
AI-Powered Causality Assessment
Intelligent drug-AE attribution using WHO-UMC and Naranjo algorithms
Automated WHO-UMC scoring
Naranjo algorithm integration
Temporal relationship analysis
Dose-response evaluation
De-challenge/re-challenge tracking
Drug Interaction Monitoring
Real-time monitoring of drug-drug, drug-food, and drug-herb interactions
CYP450 interaction analysis
Pharmacokinetic modeling
Synergistic effect monitoring
Contraindication alerts
Severity-based recommendations
Toxicity Pattern Recognition
Advanced pattern detection for cumulative and organ-specific toxicities
Cumulative dose tracking
Organ toxicity monitoring
Dose-limiting toxicity identification
Biomarker correlation analysis
Risk stratification models
Clinical Decision Support
Evidence-based recommendations for dose modifications and alternatives
Dose reduction algorithms
Alternative therapy suggestions
Supportive care protocols
Drug holiday recommendations
Safety monitoring guidelines
Comprehensive Toxicity Management
AI-powered analysis of organ-specific toxicities with evidence-based management recommendations.
Hematologic Toxicities
Blood and bone marrow toxicities
Active Toxicities:
Neutropenia
Grade 3Drug: Carboplatin
Attribution: Definite
Thrombocytopenia
Grade 2Drug: Gemcitabine
Attribution: Probable
Anemia
Grade 1Drug: Cisplatin
Attribution: Possible
Febrile Neutropenia
Grade 4Drug: Docetaxel
Attribution: Definite
Management Recommendations:
Monitor CBC q3-7 days during treatment
Consider G-CSF support for Grade 3+ neutropenia
Platelet transfusion threshold: <10,000
Dose reduction protocol for persistent Grade 2+
Seamless Clinical Workflow Integration
Integrated solutions that enhance every aspect of oncology pharmacy practice from medication reconciliation to safety monitoring.
Medication Reconciliation
AI-enhanced med rec with drug interaction screening
Automated drug database lookup
Interaction screening
Allergy cross-checking
Dose verification
Adverse Event Assessment
Structured AE evaluation with causality determination
CTCAE grading automation
Causality assessment
Rechallenge evaluation
Regulatory reporting
Dose Optimization
Evidence-based dose adjustments for safety and efficacy
PK/PD modeling
Organ function assessment
BSA/dose calculations
Protocol adherence
Safety Monitoring
Continuous monitoring for drug-related adverse events
Lab value monitoring
Vital sign tracking
Symptom assessment
Trend analysis
Real-Time Pharmacology Intelligence
Comprehensive dashboard providing instant insights into drug interactions, dose optimization opportunities, and safety monitoring requirements.
Pharmacology Intelligence Dashboard
219
Active pharmacological assessments
Drug Interactions
Critical
3
Moderate
12
Minor
28
Dose Adjustments
Critical
8
Moderate
15
Minor
22
Contraindications
Critical
1
Moderate
4
Minor
7
Monitoring Required
Critical
18
Moderate
34
Minor
67
AI Recommendations:
3 critical drug interactions require immediate attention
8 patients eligible for dose optimization this cycle
18 high-priority safety monitoring alerts pending review
Measurable Pharmacy Impact
See the concrete financial and clinical benefits of implementing AI-powered pharmacy tools.
Annual Pharmacy ROI
$712,000
Based on 200-bed oncology service with 3 pharmacists
ADR Management Efficiency
78% time savings × 12 hours/week × $50/hour × 52 weeks
$156,000
Drug Interaction Prevention
92% detection rate × prevented adverse outcomes × cost avoidance
$340,000
Improved Attribution Accuracy
94% accuracy × reduced investigation time × better outcomes
$89,000
Clinical Decision Support
Optimized dosing + reduced toxicities + improved efficacy
$127,000
Implementation Cost
Software + Training + Drug Database Integration
$67,000
Net ROI:
$645,000
ROI of 963% in first year
Trusted by Leading Oncology Pharmacists
See how oncology pharmacists are improving patient outcomes and operational efficiency with CTCAE AI.
"CTCAE AI has revolutionized our approach to drug attribution. The AI-powered causality assessment is more accurate than manual methods and saves us hours every day."
Dr. Patricia Wong, PharmD, BCOP
Oncology Clinical Pharmacist
MD Anderson Cancer Center
Key Result:
94% improvement in attribution accuracy
"The toxicity management features are incredible. We can now proactively manage adverse events and optimize dosing in real-time. Patient outcomes have significantly improved."
Mark Stevens, PharmD, RPh
Clinical Pharmacy Specialist
Mayo Clinic Cancer Center
Key Result:
78% reduction in ADR management time
Comprehensive Drug Database Integration
Connected to leading pharmaceutical databases for real-time drug information and interaction screening.
Drug Information
Comprehensive drug monographs and clinical data
Mechanism of action
Pharmacokinetics
Dosing guidelines
Administration protocols
Interaction Screening
Real-time drug-drug and drug-disease interaction checking
CYP450 interactions
Pharmacodynamic effects
Contraindications
Severity scoring
Safety Monitoring
Evidence-based monitoring recommendations and protocols
Lab monitoring
Vital sign tracking
Adverse event profiles
Risk mitigation
Ready to Transform Your Pharmacy Practice?
Join leading oncology pharmacists using CTCAE AI to improve drug attribution accuracy, optimize patient safety, and deliver evidence-based pharmaceutical care.
✓ 30-day clinical trial ✓ Drug database integration included ✓ 24/7 pharmacy support